Latest Posts

27

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

18

Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience.

Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce their strategic partnership, aimed at revolutionizing the biopharma industry. By leveraging Partex’s proprietary AI (Artificial Intelligence) technology and Anavex’s innovative precision medicine drug development platform, we seek to enhance patient outcomes and reshape the future of healthcare.

Dr. Gunjan Bhardwaj, CEO of Partex NV, expressed his excitement, stating, “Together with Anavex, we embark on this impactful journey to extend our patient ecosystem. Our Life Sciences Language Processing platform with Generative Artificial Intelligence capabilities will significantly improve patient outcomes.”

Dr. Christopher Missling, PhD, President and CEO of Anavex Life Sciences, added, “We are thrilled to collaborate with Partex and fully embrace AI to expand beyond R&D into healthcare sales marketing. Our expertise in precision medicine drug development, combined with Partex’s disruptive approach, will bring better treatment options to patients in a truly patient-centric manner.”

Stay tuned for the groundbreaking advancements we’ll achieve together. Together, we are reshaping the future of biopharma.

Read more

Featured News

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…